Works matching IS 17470277 AND DT 2024 AND VI 103 AND IP 4
Results: 18
Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14529
- By:
- Publication type:
- Article
Correction to "Brucine D restrains colorectal cancer tumorigenesis and autophagy by downregulating circ_0068464".
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction to Analysis of bioactive compounds using LC–ESI–MS/MS, cytotoxic, antimicrobial effects, and enzyme activities from Cyclotrichium origanifolium.
- Published in:
- 2024
- Publication type:
- Correction Notice
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14525
- By:
- Publication type:
- Article
Corrigendum to 'Sinigrin improves cerebral ischaemia‐reperfusion injury by inhibiting the TLR4 pathway‐mediated oxidative stress'.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction to "Prostaglandin E2 may clinically alleviate dry eye disease by inducing Th17 cell differentiation".
- Published in:
- 2024
- Publication type:
- Correction Notice
Baicalin inhibits monosodium urate crystal‐induced pyroptosis in renal tubular epithelial cell line through Panx‐1/P2X7 pathways: Molecular docking, molecular dynamics, and in vitro experiments.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14522
- By:
- Publication type:
- Article
Anticancer mechanisms of β‐carbolines.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14521
- By:
- Publication type:
- Article
Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK/PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14520
- By:
- Publication type:
- Article
Kaempferol attenuates inflammation in lipopolysaccharide‐induced gallbladder epithelial cells by inhibiting the MAPK/NF‐κB signaling pathway.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14519
- By:
- Publication type:
- Article
Icariin alleviates the apoptosis of chondrocytes in osteoarthritis through regulating SIRT‐1‐Nrf2‐HO‐1 signaling.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14518
- By:
- Publication type:
- Article
EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14517
- By:
- Publication type:
- Article
Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D‐Cys6‐LHRH vedotin, against ovarian cancer cell lines.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14516
- By:
- Publication type:
- Article
Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14515
- By:
- Publication type:
- Article
Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14513
- By:
- Publication type:
- Article
Design, synthesis and characterization of ethyl 3‐benzoyl‐7‐morpholinoindolizine‐1‐carboxylate as anti‐tubercular agents: In silico screening for possible target identification.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14512
- By:
- Publication type:
- Article
Mechanistic insights into targeting caspase‐3 activation and alveolar macrophage pyroptosis by Ephedra and bitter almond compounds for treating pediatric pneumonia via network pharmacology and bioinformatics.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14487
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 4, p. 1, doi. 10.1111/cbdd.14075
- Publication type:
- Article